Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease

NCT06959524 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06959524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06959524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
August 21, 2025
Completion date
March 31, 2032
Enrollment
1,616 (estimated)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), de novo lesions in native coronary arteries